| Expression pattern: |
DN |
| Associated gene: |
VCP, Beclin 1, ataxin-3 |
| Associated microRNA: |
miR-558 |
| Biological function: |
Inhibits bladder cancer cell proliferation and suppresses autophagy. |
| Molecular mechanism: |
circHIPK3 binds VCP and blocks the VCP/Beclin 1 interaction, thereby inhibiting VCP-mediated autophagy (non-classical ceRNA mechanism). |
| Biological pathway or process: |
autophagy (inhibits); proliferation (inhibits); PI3K/AKT (other) |
| Detected method: |
Q
|
| Validation methods: |
RT-qPCR; Clinical Sample Validation; FISH / smFISH; RIP (RNA Immunoprecipitation); RNA Pull-Down; Western Blot; Co-IP; IF (Immunofluorescence); Transfection; CCK8; EdU Staining; In Vivo Animal Model; IHC (Immunohistochemistry) |
| Clinical significance: |
circHIPK3 was negatively correlated with bladder cancer grade, invasion, and lymph node metastasis; proposed as a biomarker for bladder cancer. |
| Description: |
circHIPK3 (hsa_circ_0000284) is down-regulated in bladder cancer tissues and cell lines and acts as a tumor suppressor. It inhibits proliferation and autophagy by directly binding VCP and weakening the VCP-Beclin 1 interaction, reducing Beclin 1-associated autophagy activity. |
| Confidence score: |
0.7788 |